Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FYBHB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg tablets (120-count units). The award, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, utilizes a firm fixed-price contract type with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide.
Xtandi is an oncology treatment used in prostate cancer therapy, reflecting DMS Pharmaceutical Group's established role as a critical supplier of specialized prescription medications to Department of Defense healthcare sites. The company's federal contracting portfolio demonstrates consistent success in competing for pharmaceutical delivery orders across multiple therapeutic categories, including branded and generic prescription drugs, biologics, and medical consumables. This award continues DMS Pharmaceutical Group's operational support of the military health system's pharmaceutical supply chain, with performance expected at the company's primary location in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DB25FYBHB?
SPE2DB25FYBHB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FYBHB worth?
The government has obligated $8,339 on SPE2DB25FYBHB.
Is contract SPE2DB25FYBHB an order under another contract?
Yes. SPE2DB25FYBHB is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBHB competed?
The extent of competition for SPE2DB25FYBHB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award